Edge Advisors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Edge Advisors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2018$11,000
-42.1%
128
-51.9%
0.00%
-50.0%
Q1 2018$19,000
+26.7%
2660.0%0.00%
+100.0%
Q4 2017$15,000
+36.4%
2660.0%0.00%0.0%
Q3 2017$11,000
-35.3%
266
-40.5%
0.00%
-50.0%
Q2 2017$17,0000.0%4470.0%0.00%0.0%
Q1 2017$17,0000.0%447
+1.6%
0.00%0.0%
Q4 2016$17,0004400.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders